395 related articles for article (PubMed ID: 7906974)
1. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
Hoermann R; Schumm-Draeger PM; Mann K
Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
[TBL] [Abstract][Full Text] [Related]
2. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
[TBL] [Abstract][Full Text] [Related]
3. Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.
Hoermann R; Schumm-Draeger PM; Rehbach K; Mann K
J Clin Invest; 1991 Dec; 88(6):1947-54. PubMed ID: 1752954
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease: xenotransplantation model (athymic nude mice).
Jungheim K; Schumm-Draeger PM; Usadel KH
J Mol Med (Berl); 1999 Jan; 77(1):185-8. PubMed ID: 9930960
[TBL] [Abstract][Full Text] [Related]
6. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of the human TSH receptor: in vitro and in vivo studies of their functional and immunological effects.
Hoermann R; Schumm-Draeger PM; Mann K
Exp Clin Endocrinol; 1992; 100(1-2):36-40. PubMed ID: 1468513
[TBL] [Abstract][Full Text] [Related]
8. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
[TBL] [Abstract][Full Text] [Related]
10. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
11. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice.
Flynn JC; Gilbert JA; Meroueh C; Snower DP; David CS; Kong YC; Banga JP
Immunology; 2007 Oct; 122(2):261-7. PubMed ID: 17535305
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.
Kasuga Y; Matsubayashi S; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1991 Jun; 72(6):1296-301. PubMed ID: 1902846
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
15. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
[TBL] [Abstract][Full Text] [Related]
16. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
17. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
[TBL] [Abstract][Full Text] [Related]
18. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.
Carayanniotis G; Huang GC; Nicholson LB; Scott T; Allain P; McGregor AM; Banga JP
Clin Exp Immunol; 1995 Feb; 99(2):294-302. PubMed ID: 7851025
[TBL] [Abstract][Full Text] [Related]
19. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
